Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.
- NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_assertion description "[The results show that combination immunotherapy consisting of vaccination with a synthetic peptide corresponding to an immunodominant CTL epitope derived from tyrosinase-related protein-2 administered with CpG-ODN adjuvant and followed by systemic injection of anti-CTLA-4 antibodies increased the survival of mice against the poorly immunogenic B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.
- NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_assertion evidence source_evidence_literature NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.
- NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_assertion SIO_000772 12810660 NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.
- NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_assertion wasDerivedFrom befree-20140225 NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.
- NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_assertion wasGeneratedBy ECO_0000203 NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.
- befree-20140225 importedOn "2014-02-25" NP538461.RAe9kUk4aFnXgGecnPoXLS4faDlR9XZVVoeNLyKUOGi4k130_provenance.